Table 2.

Multiple Logistic Regression Model of Factors Associated with Social Information Needs

	Talk about cancer with family and friends (TAC)			Meet peer survivors (MPS)a
	n=439, adjusted r2=0.25			n=424, adjusted r2=0.29
	OR	95% CI	p	OR	95% CI	p
Sociodemographics
Age at diagnosis
15–19	Ref			Ref
20–29	2.1	0.8–5.4	0.13	2.3	1.1–4.9	0.03
30–39	2.1	0.8–5.4	0.13	1.7	0.8–3.8	0.17
Gender
Male	Ref			Ref
Female	0.6	0.3–1.1	0.08	0.7	0.4–1.2	0.14
Race/ethnicity
Non-Hispanic white	Ref			Ref
Non-Hispanic black	1.7	0.7–4.4	0.26	1.2	0.5–2.7	0.70
Hispanic	2.4	1.3–4.6	0.01	1.7	1.0–3.2	0.07
Other/unknown	2.4	1.1–5.3	0.03	1.5	0.7–3.3	0.26
Clinical/health variables
Cancer site
Germ cell	Ref			Ref
Hodgkin lymphoma	0.9	0.3–2.0	0.70	1.1	0.6–2.0	0.85
NHL	0.6	0.2–1.3	0.17	1.1	0.6–2.0	0.86
ALL	0.1	0.01–1.0	0.05	1.2	0.4–4.1	0.76
Sarcomab	0.6	0.2–2.2	0.40	1.2	0.4–3.4	0.76
Treatment
No/missing/unknown	Ref
Surgery only	0.3	0.05–1.5	0.14	—	—	—
Radiation (w/ or w/o surgery)	0.2	0.04–1.2	0.08	—	—	—
Chemotherapy (w/ or w/o surgery)	0.3	0.07–1.4	0.13	—	—	—
Radiation and chemo (w/ or w/o surgery)	0.6	0.1–2.5	0.45	—	—	—
Comorbidities
0	Ref			Ref
1	0.9	0.4–1.8	0.73	1.2	0.7–2.2	0.50
2+	1.4	0.7–3.0	0.36	1.1	0.5–2.3	0.88
Quality of care
Excellent/very good	Ref			Ref
Good	1.3	0.63–2.5	0.53	1.0	0.5–2.0	0.94
Fair/poor	3.6	1.1–11.7	0.03	2.2	0.6–8.5	0.25
Symptoms
0–1	Ref			Ref
2–3	1.5	0.7–3.0	0.27	1.5	0.8–2.6	0.19
4+	2.9	1.5–5.5	0.001	2.3	1.3–3.9	0.004
Support group services
Received	Ref			Ref
Not received/not needed	0.9	0.4–2.1	0.77	0.6	0.3–1.3	0.22
Not received/needed	3.6	1.3–9.8	0.01	13.3	4.2–42.3	<0.0001

Odds ratios with p values<0.05 are indicated in bold.

^aOdds ratios adjusted for every other variable in model. MPS model does not include treatment history.

^bSarcoma types included Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

ALL, acute lymphoblastic leukemia; CI, confidence interval; NHL, non-Hodgkin lymphoma; OR, odds ratio; Ref, reference; w/, with; w/o, without.